Kidney Transplant Rejection - Pipeline Review, H1 2018 by MarketResearchReports.biz
"The Report Kidney
Transplant Rejection - Pipeline Review, H1 2018 provides information
on pricing, market analysis, shares, forecast, and company profiles
for key industry participants. - MarketResearchReports.biz"
About
Kidney
Transplant Rejection
Market
Global Markets Direct's latest
Pharmaceutical and Healthcare disease pipeline guide Kidney
Transplant Rejection - Pipeline Review, H1 2018, provides an overview
of the Kidney Transplant Rejection (Immunology) pipeline landscape.
Kidney transplantation is a
therapy performed to replace a diseased kidney with a healthy kidney
from another person. Risk factors associated with transplantation are
bleeding, infection, blockage of the blood vessels to the new kidney,
leakage of urine or blockage of urine in the ureter and initial lack
of function of the new kidney. Treatment includes immunosuppressive
drugs to prevent organ rejection.
Get
Sample copy of this Report @
https://www.marketresearchreports.biz/sample/sample/1743248
Report Highlights
Global Markets Direct's
Pharmaceutical and Healthcare latest pipeline guide Kidney Transplant
Rejection - Pipeline Review, H1 2018, provides comprehensive
information on the therapeutics under development for Kidney
Transplant Rejection (Immunology), complete with analysis by stage of
development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type.
The guide covers the descriptive
pharmacological action of the therapeutics, its complete research and
development history and latest news and press releases.
The
Kidney Transplant Rejection (Immunology) pipeline guide also reviews
of key players involved in therapeutic development for Kidney
Transplant Rejection and features dormant and discontinued projects.
The guide covers therapeutics
under Development by Companies /Universities /Institutes, the
molecules developed by Companies in Pre-Registration, Phase III,
Phase II, Phase I, Preclinical and Discovery stages are 1, 7, 10, 10,
16 and 3 respectively. Similarly, the Universities portfolio in Phase
II and Phase I stages comprises 1 and 1 molecules, respectively.
Request
for TOC @
https://www.marketresearchreports.biz/reports/1743248/kidney-transplant-rejection-pipeline-review-h1-2018-market-research-reports/toc
Kidney Transplant Rejection
(Immunology) pipeline guide helps in identifying and tracking
emerging players in the market and their portfolios, enhances
decision making capabilities and helps to create effective counter
strategies to gain competitive advantage.
The guide is built using data and
information sourced from Global Markets Directs proprietary
databases, company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and featured press
releases from company/university sites and industry-specific third
party sources. Additionally, various dynamic tracking processes
ensure that the most recent developments are captured on a real time
basis.
Note: Certain content / sections
in the pipeline guide may be removed or altered based on the
availability and relevance of data.
Scope
- The pipeline guide provides a
snapshot of the global therapeutic landscape of Kidney Transplant
Rejection (Immunology).
- The pipeline guide reviews
pipeline therapeutics for Kidney Transplant Rejection (Immunology) by
companies and universities/research institutes based on information
derived from company and industry-specific sources.
- The pipeline guide covers
pipeline products based on several stages of development ranging from
pre-registration till discovery and undisclosed stages.
- The pipeline guide features
descriptive drug profiles for the pipeline products which comprise,
product description, descriptive licensing and collaboration details,
R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key
companies involved in Kidney Transplant Rejection (Immunology)
therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates
Kidney Transplant Rejection (Immunology) therapeutics based on
mechanism of action (MoA), drug target, route of administration (RoA)
and molecule type.
- The pipeline guide encapsulates
all the dormant and discontinued pipeline projects.
- The pipeline guide reviews
latest news related to pipeline therapeutics for Kidney Transplant
Rejection (Immunology)
Reasons to buy
- Procure strategically important
competitor information, analysis, and insights to formulate effective
R&D strategies.
- Recognize emerging players with
potentially strong product portfolio and create effective
counter-strategies to gain competitive advantage.
- Find and recognize significant
and varied types of therapeutics under development for Kidney
Transplant Rejection (Immunology).
- Classify potential new clients
or partners in the target demographic.
- Develop tactical initiatives by
understanding the focus areas of leading companies.
- Plan mergers and acquisitions
meritoriously by identifying key players and its most promising
pipeline therapeutics.
- Formulate corrective measures
for pipeline projects by understanding Kidney Transplant Rejection
(Immunology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing
and out-licensing strategies by identifying prospective partners with
the most attractive projects to enhance and expand business potential
and scope.
- Adjust the therapeutic portfolio
by recognizing discontinued projects and understand from the know-how
what drove them from pipeline.
Table of Contents
Table of Contents 2
Introduction 5
Kidney Transplant Rejection -
Overview 6
Kidney Transplant Rejection -
Therapeutics Development 7
Kidney Transplant Rejection -
Therapeutics Assessment 16
Kidney Transplant Rejection -
Companies Involved in Therapeutics Development 24
Kidney Transplant Rejection - Drug
Profiles 35
Kidney Transplant Rejection -
Dormant Projects 145
Kidney Transplant Rejection -
Discontinued Products 148
Kidney Transplant Rejection -
Product Development Milestones 149
Appendix 159
List of Tables
Number of Products under
Development for Kidney Transplant Rejection, H1 2018
Number of Products under
Development by Companies, H1 2018
Number of Products under
Development by Universities/Institutes, H1 2018
Products under Development by
Companies, H1 2018
Products under Development by
Universities/Institutes, H1 2018
Number of Products by Stage and
Target, H1 2018
Number of Products by Stage and
Mechanism of Action, H1 2018
Number of Products by Stage and
Route of Administration, H1 2018
Number of Products by Stage and
Molecule Type, H1 2018
Kidney Transplant Rejection -
Pipeline by Amgen Inc, H1 2018
Kidney Transplant Rejection -
Pipeline by Angion Biomedica Corp, H1 2018
Kidney Transplant Rejection -
Pipeline by Astellas Pharma Inc, H1 2018
Kidney Transplant Rejection -
Pipeline by Balmes Transplantation SAS, H1 2018
Kidney Transplant Rejection -
Pipeline by Bioverativ Inc, H1 2018
Kidney Transplant Rejection -
Pipeline by Catalyst Biosciences Inc, H1 2018
Kidney Transplant Rejection -
Pipeline by CSL Ltd, H1 2018
Kidney Transplant Rejection -
Pipeline by Gilead Sciences Inc, H1 2018
Kidney Transplant Rejection -
Pipeline by GlaxoSmithKline Plc, H1 2018
Kidney Transplant Rejection -
Pipeline by Hansa Medical AB, H1 2018
Kidney Transplant Rejection -
Pipeline by Idogen AB, H1 2018
Kidney Transplant Rejection -
Pipeline by ITB-Med AB, H1 2018
Kidney Transplant Rejection -
Pipeline by Johnson & Johnson, H1 2018
Kidney Transplant Rejection -
Pipeline by Kyowa Hakko Kirin Co Ltd, H1 2018
Kidney Transplant Rejection -
Pipeline by Magnus Life Ltd, H1 2018
Kidney Transplant Rejection -
Pipeline by Noorik Biopharmaceuticals AG, H1 2018
Kidney Transplant Rejection -
Pipeline by Novartis AG, H1 2018
Kidney Transplant Rejection -
Pipeline by Opsona Therapeutics Ltd, H1 2018
Kidney Transplant Rejection -
Pipeline by Pharmicell Co Ltd, H1 2018
Kidney Transplant Rejection -
Pipeline by Prolong Pharmaceuticals LLC, H1 2018
Kidney Transplant Rejection -
Pipeline by Quark Pharmaceuticals Inc, H1 2018
Kidney Transplant Rejection -
Pipeline by Shire Plc, H1 2018
Kidney Transplant Rejection -
Pipeline by TolerogenixX GmbH, H1 2018
Kidney Transplant Rejection -
Pipeline by TxCell SA, H1 2018
Kidney Transplant Rejection -
Dormant Projects, H1 2018
Kidney Transplant Rejection -
Discontinued Products, H1 2018
List of Figures
Number of Products under
Development for Kidney Transplant Rejection, H1 2018
Number of Products under
Development by Companies, H1 2018
Number of Products under
Development by Universities/Institutes, H1 2018
Number of Products by Top 10
Targets, H1 2018
Number of Products by Stage and
Top 10 Targets, H1 2018
Number of Products by Top 10
Mechanism of Actions, H1 2018
Number of Products by Stage and
Top 10 Mechanism of Actions, H1 2018
Number of Products by Routes of
Administration, H1 2018
Number of Products by Stage and
Routes of Administration, H1 2018
Number of Products by Top 10
Molecule Types, H1 2018
Number of Products by Stage and
Top 10 Molecule Types, H1 2018
About us
MarketResearchReports.biz is the
most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Comments
Post a Comment